Avatrombopag Maleate
Brand name: Doptelet
Rank #471 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$15.4M
Total Cost
1,156
Total Claims
$15.4M
Total Cost
75
Prescribers
$13K
Cost per Claim
12
Beneficiaries
1,167
30-Day Fills
$206K
Avg Cost/Provider
15
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$15.4M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $15.4M total
🔎 Data Overview
At $13,353 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $205,810 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $1,286,315 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Avatrombopag Maleate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Scott Mcgee | Hematology-Oncology | Massillon, OH | 75 | $1.3M |
| 2 | Susie Lee | Physician Assistant | Los Angeles, CA | 37 | $499K |
| 3 | Noman Rafique | Hematology-Oncology | Massillon, OH | 34 | $496K |
| 4 | Edward Jamelarin | Hematology-Oncology | Columbus, OH | 30 | $440K |
| 5 | Brent Limbaugh | Hematology-Oncology | Augusta, GA | 25 | $359K |
| 6 | Morey Blinder | Hematology | Saint Louis, MO | 21 | $350K |
| 7 | Don Park | Hematology-Oncology | Allentown, PA | 18 | $340K |
| 8 | Deepa Reddy | Hematology-Oncology | San Leandro, CA | 14 | $331K |
| 9 | Shahrooz Eshaghian | Hematology-Oncology | Los Angeles, CA | 18 | $299K |
| 10 | Vinod Pullarkat | Hematology | Duarte, CA | 14 | $289K |
| 11 | Grant Lewis | Hematology-Oncology | Savannah, GA | 11 | $277K |
| 12 | Aneesha Ananthula | Hematology-Oncology | Duluth, GA | 11 | $276K |
| 13 | Scott Sonnier | Hematology-Oncology | New Orleans, LA | 13 | $273K |
| 14 | Abdul Haseeb | Hematology-Oncology | Fresno, CA | 18 | $273K |
| 15 | Joshua Weese | Hematology-Oncology | Roseburg, OR | 11 | $271K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 468 | Prucalopride Succinate (Motegrity) | $15.7M | 22,068 |
| 469 | Ketorolac Tromethamine (Ketorolac Tromethamine) | $15.6M | 582,750 |
| 470 | Tetrabenazine (Tetrabenazine) | $15.6M | 6,326 |
| 471 | Avatrombopag Maleate (Doptelet) | $15.4M | 1,156 |
| 472 | Primidone (Primidone) | $15.3M | 450,535 |
| 473 | Fluocinonide (Fluocinonide) | $15.3M | 217,528 |
| 474 | Diclofenac Potassium (Diclofenac Potassium) | $15.2M | 96,736 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology